TearLab (TEAR) Stabilizes After Massive 2-Day Slide
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- Wall Street retreats as renewed Middle East strife hits sentiment; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil gains over 5% as Trump says US reinstating Iran naval blockade
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street retreats as renewed Middle East strife hits sentiment; chipmakers drop
- Oncolytics to meet FDA on registrational path for REO 033 trial
TearLab (TEAR) Price Target Raised to $18 at Craig-Hallum
August 5, 2013 10:38 AM EDTCraig-Hallum maintained a Buy rating on TearLab (NASDAQ: TEAR) and raised its price target to $18.00 (from $16.00).
For an analyst ratings summary and ratings history on TearLab click here. For more ratings news on TearLab click here.
Shares of TearLab closed at $12.20 yesterday, with a 52 week range of $3.10-$15.18.... More
TearLab (TEAR) Falls on Sweeper Report
August 1, 2013 12:07 PM EDTTearLab Corporation (Nasdaq: TEAR) stock declined on Thursday after it received negative coverage in StreetSweeper. The report said doctors are not happy with the company's diagnostic test for dry eye disease.... More
